Evidence map›Paper›PMID 40872566›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Development of AGT-7: An Innovative

Stavroula G Kyrkou, Vasileios-Panagiotis Bistas, Evangelia-Alexandra Salvanou, Timothy Crook, Maria Giannakopoulou, Vasiliki Zoi, Maximos Leonardos, Andreas Fotopoulos, Chrissa Sioka, Ioannis Leonardos and 3 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Stavroula G KyrkouDepartment of Chemistry, Section of Organic Chemistry and Biochemistry, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0003-4096-9046
Vasileios-Panagiotis BistasDepartment of Chemistry, Section of Organic Chemistry and Biochemistry, University of Ioannina, 45110 Ioannina, Greece.ORCID 0009-0004-2024-0949
Evangelia-Alexandra SalvanouInstitute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research "Demokritos", 15341 Athens, Greece.ORCID 0009-0001-2091-0234
Timothy CrookJohn Fulcher Neuro-Oncology Laboratory, Department of Brain Sciences, Division of Neuroscience, Faculty of Medicine, Imperial College London, London W12 0NN, UK.
Maria GiannakopoulouNeurosurgical Institute, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
Vasiliki ZoiNeurosurgical Institute, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0003-4655-9726
Maximos LeonardosLaboratory of Zoology, Department of Biological Applications and Technologies, University of Ioannina, 45110 Ioannina, Greece.ORCID 0009-0006-1951-8135
Andreas FotopoulosNeurosurgical Institute, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
Chrissa SiokaNeurosurgical Institute, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0002-2184-4945
Ioannis LeonardosLaboratory of Zoology, Department of Biological Applications and Technologies, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0001-8429-8200
George A AlexiouNeurosurgical Institute, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0003-0257-4481
Penelope BouziotisInstitute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Center for Scientific Research "Demokritos", 15341 Athens, Greece.ORCID 0000-0001-6778-2201
Andreas G TzakosDepartment of Chemistry, Section of Organic Chemistry and Biochemistry, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0001-6391-0288

Funding

This research was funded by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH-CREATE-INNOVATE (project code: TAED AEDK-06189/ Τ2EDK-0326
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

glioblastomaradiopharmaceuticalsSPECTtechnetium-99m molecular imagingtemozolamideTetrofosmintheranostics

Identifiers

PMID40872566
PMCPMC12388980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.